New report finds a potential result of disclosure requirements could increase federal government costs by $134 billion over 10 years Congress continues to consider proposals that could require pharmacy benefit companies to publicly disclose contracted manufacturer rebate amounts – information
Prescription Drug Rebates Negotiating rebates on prescription drugs is one way PBMs work to bring down health care costs down. Drug manufacturers compete against each other for formulary coverage by negotiating rebates with PBMs. Rebates are the key to PBMs’
Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
“In effect, the era of high list prices and high rebates for insulin is over” In case you missed it, Alex Brill, founder and CEO of Matrix Global Advisors (MGA) and former policy director and chief economist for the House
Last week, the U.S. House Ways and Means Committee Health Subcommittee held a hearing on “Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.” During the hearing, Congressman Kevin Hern (R-OK) shared that, as a former business owner, he was
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the recent announcement from the Centers for Medicare and Medicaid Services (CMS) to allow Medicare Part D plans to substitute all FDA-approved biosimilars on their formularies.
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. Pandemic Vaccine: Safety Top Priority for Rx Supply Chain… As states
(Washington, D.C.) — A new report, “Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent evidence showing that prescription drug rebates negotiated by pharmacy benefit managers (PBMs) reduce drug
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on the legislative markup on S. 1339, the Pharmacy Benefit Manager Reform Act, by the U.S. Health, Education, Labor & Pensions (HELP) Committee. “Just one day
©2024 PCMA. All Rights Reserved.
